Zilebesiran
Click below to learn more about zilebesiran through educational and scientific materials.
About Zilebesiran
Publication Date
July 2023
Journal
The New England Journal of Medicine
Authors
Akshay Desai, David Webb, Jorg Taubel, et al
Publication Date
February 2024
Journal
The Journal of the American Medical Association
Authors
George L Bakris, Manish Saxena, Anil Gupta, et al
Publication Date
July 2025
Journal
The Journal of the American Medical Association
Authors
Akshay S Desai, Adam D Karns, Jolita Badariene, et al
For more information about data regarding zilebesiran, please visit our Congresses & Publications page.
Currently Enrolling Trials
Phase/Status |
Trial Name |
Description |
|---|---|---|
Phase 3 |
Image
|
ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
ClinicalTrials.gov: NCT07181109
|
Phase/Status |
|---|
Phase 3 |
Trial Name |
|---|
Image
|
Description |
|---|
ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
ClinicalTrials.gov: NCT07181109
|
*Additional eligibility criteria apply.
